Log In
Print
BCIQ
Print
Print this Print this
 

GSK2248761 (formerly IDX899)

Also known as: 2248761 (GSK 2248761)

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Molecular Target
Mechanism of ActionNon-nucleoside reverse transcriptase inhibitor (NNRTI)
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection
Regulatory Designation
Partner GlaxoSmithKline plc; ViiV Healthcare Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$450.5M

$17.0M

$416.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today